S&P 500

6.051,09

0,00%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
OpGen Inc (OPGN)
OpGen Inc (OPGN) Notícias

OPGN

OpGen (OPGN)

OpGen Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:OPGN

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
24/09/2024	14:43	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:OPGN	OpGen Inc
28/08/2024	13:59	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OPGN	OpGen Inc
22/08/2024	18:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OPGN	OpGen Inc
19/08/2024	18:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OPGN	OpGen Inc
19/08/2024	17:56	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:OPGN	OpGen Inc
14/08/2024	17:05	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:OPGN	OpGen Inc
01/08/2024	18:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OPGN	OpGen Inc
01/08/2024	18:25	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:OPGN	OpGen Inc
01/08/2024	13:26	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:OPGN	OpGen Inc
30/05/2024	17:30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:OPGN	OpGen Inc
24/05/2024	17:05	GlobeNewswire Inc.	OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q	NASDAQ:OPGN	OpGen Inc
16/05/2024	08:00	GlobeNewswire Inc.	OpGen Announced 1-for-10 Reverse Stock Split	NASDAQ:OPGN	OpGen Inc
29/04/2024	17:05	GlobeNewswire Inc.	OpGen Provides Update on Business Operations and Strategic Opportunities	NASDAQ:OPGN	OpGen Inc
23/04/2024	17:15	GlobeNewswire Inc.	OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K	NASDAQ:OPGN	OpGen Inc
26/03/2024	17:20	AllPennyStocks.com	Shares Rip In Reaction To Activist Investor Becoming CEO	NASDAQ:OPGN	OpGen Inc
25/03/2024	17:05	GlobeNewswire Inc.	OpGen Announces Acquisition of Preferred Stock by David Lazar	NASDAQ:OPGN	OpGen Inc
24/11/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OPGN	OpGen Inc
14/11/2023	18:30	GlobeNewswire Inc.	OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
13/11/2023	18:59	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OPGN	OpGen Inc
13/10/2023	18:18	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:OPGN	OpGen Inc
13/10/2023	18:17	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OPGN	OpGen Inc
12/10/2023	13:32	GlobeNewswire Inc.	OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds	NASDAQ:OPGN	OpGen Inc
28/09/2023	17:24	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:OPGN	OpGen Inc
10/08/2023	17:15	GlobeNewswire Inc.	OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:OPGN	OpGen Inc
07/08/2023	08:30	GlobeNewswire Inc.	OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering	NASDAQ:OPGN	OpGen Inc
03/08/2023	09:00	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement	NASDAQ:OPGN	OpGen Inc
03/08/2023	08:30	GlobeNewswire Inc.	OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time	NASDAQ:OPGN	OpGen Inc
01/08/2023	10:40	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:OPGN	OpGen Inc
21/07/2023	17:55	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:OPGN	OpGen Inc
19/07/2023	08:30	GlobeNewswire Inc.	OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND	NASDAQ:OPGN	OpGen Inc